DK191D0 - Ledersekvens, der frembringer en post-translational modifikation af polypeptider i bakterier, samt gen derfor - Google Patents

Ledersekvens, der frembringer en post-translational modifikation af polypeptider i bakterier, samt gen derfor

Info

Publication number
DK191D0
DK191D0 DK000191A DK191A DK191D0 DK 191 D0 DK191 D0 DK 191D0 DK 000191 A DK000191 A DK 000191A DK 191 A DK191 A DK 191A DK 191 D0 DK191 D0 DK 191D0
Authority
DK
Denmark
Prior art keywords
polypeptides
post
leader sequence
bacteries
translational modification
Prior art date
Application number
DK000191A
Other languages
English (en)
Other versions
DK191A (da
Inventor
Norman J Hansen
Original Assignee
Univ Maryland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maryland filed Critical Univ Maryland
Publication of DK191A publication Critical patent/DK191A/da
Publication of DK191D0 publication Critical patent/DK191D0/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/90—Fusion polypeptide containing a motif for post-translational modification

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK000191A 1988-07-05 1991-01-02 Ledersekvens, der frembringer en post-translational modifikation af polypeptider i bakterier, samt gen derfor DK191D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/214,959 US5218101A (en) 1988-07-05 1988-07-05 Leader sequence inducing a post-translational modification of polypeptides in bacteria, and gene therefor
PCT/US1989/002820 WO1990000558A1 (en) 1988-07-05 1989-06-30 Leader sequence inducing a post-translational modification of polypeptides in bacteria, and gene therefor

Publications (2)

Publication Number Publication Date
DK191A DK191A (da) 1991-01-02
DK191D0 true DK191D0 (da) 1991-01-02

Family

ID=22801074

Family Applications (1)

Application Number Title Priority Date Filing Date
DK000191A DK191D0 (da) 1988-07-05 1991-01-02 Ledersekvens, der frembringer en post-translational modifikation af polypeptider i bakterier, samt gen derfor

Country Status (14)

Country Link
US (1) US5218101A (da)
EP (1) EP0423224B1 (da)
JP (2) JP3326172B2 (da)
KR (1) KR0137961B1 (da)
AT (1) ATE175417T1 (da)
AU (1) AU640110B2 (da)
CA (1) CA1339414C (da)
DE (2) DE68928899D1 (da)
DK (1) DK191D0 (da)
IL (1) IL90832A (da)
NO (1) NO309200B1 (da)
NZ (1) NZ229538A (da)
WO (1) WO1990000558A1 (da)
ZA (1) ZA894721B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516682A (en) * 1988-07-05 1996-05-14 University Of Maryland Subtilin variant of enhanced stability and activity
US5348881A (en) * 1990-03-13 1994-09-20 Quest International Flavors & Good Ingredients Company, Division Of Indopco, Inc. Multiple bacteriocin producing lactococcus and compositions
NL9000753A (nl) * 1990-03-30 1991-10-16 Nl Zuivelonderzoek Inst Dna-fragment, ten minste coderend voor een deel van het extracellulaire eiwit met een schijnbaar molecuulgewicht van 60 kda van lactococcus lactis stammen zoals de lactococcus lactis ssp. lactis stam mg1363, combinaties hiervan met voor homologe of heterologe eiwitten coderende dna-sequenties alsmede de hiermee verkregen homologe en heterologe eiwitten.
WO1992018633A1 (en) * 1991-04-11 1992-10-29 Stichting Nederlands Instituut Voor Zuivelonderzoek (Nizo) Lantibiotics similar to nisin a, lactic acid bacteria which produce such lantibiotics, method for constructing such lactic acid bacteria and method for preserving foodstuffs with the aid of these lantibiotics and these lactic acid bacteria producing lantibiotics
US5861376A (en) * 1991-07-01 1999-01-19 Quest International Flavors & Food Ingredients Company, Division Of Indopco, Inc. Synthetically derived peptide
GB9207267D0 (en) * 1992-04-02 1992-05-13 Agricultural & Food Res Nisins
ATE255165T1 (de) * 1994-09-12 2003-12-15 Aventis Pharma Gmbh Rekombinantes mersacidin und verfahren zu seiner herstellung
US5919695A (en) * 1997-04-22 1999-07-06 Quest International, B.V. Method and culture for inhibiting undesired microorganisms with culture of Bacillus subtilis
US6953683B2 (en) * 1997-07-18 2005-10-11 University Of Maryland Compositions and methods of inhibiting bacterial spore germination
US6541607B1 (en) * 1997-07-18 2003-04-01 University Of Maryland Sublancin lantibiotic produced by Bacillus subtilis 168
CA2356955A1 (en) * 1998-12-24 2000-07-06 University Of Maryland Stable subtilin and methods of manufacture
US6759205B2 (en) 2000-06-29 2004-07-06 University Of Maryland Construction of a strain of Bacillus subtilis 168 that displays the sublancin lantibiotic on the surface of the cell
US6846804B2 (en) * 2000-06-29 2005-01-25 University Of Maryland, College Park Office Of Technology Commercialization Construction of a structural variant of sublancin to facilitate its isolation and use in bioremediation of environmental contamination by gram-positive spore formers such as bacillus anthrasis
US7033766B2 (en) * 2000-06-29 2006-04-25 University Of Maryland Office Of Technology Commercialization Construction and screening of lantibody display libraries
WO2003063887A1 (en) * 2002-01-14 2003-08-07 University Of Maryland, College Park Compositions and method of inhibiting bacterial spore germination
US6861236B2 (en) * 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
ATE408016T1 (de) * 2004-12-07 2008-09-15 Applied Nanosystems Bv Verfahren zur herstellung und sekretion modifizierter peptide
KR20080106545A (ko) * 2006-02-13 2008-12-08 베링거잉겔하임베트메디카게엠베하 란티바이오틱의 제조 방법
US7910695B2 (en) * 2006-06-29 2011-03-22 The Invention Science Fund I, Llc Methods for arbitrary peptide synthesis
US7888465B2 (en) * 2006-06-29 2011-02-15 The Invention Science Fund, I, LLC Methods for arbitrary peptide synthesis
US7879975B2 (en) * 2006-06-29 2011-02-01 The Invention Science Fund I, Llc Methods for arbitrary peptide synthesis
US7923533B2 (en) * 2006-06-29 2011-04-12 The Invention Science Fund I, Llc Methods for arbitrary peptide synthesis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716115A (en) * 1983-09-06 1987-12-29 Microlife Technics, Inc. Derived nisin producing microorganisms, method of production and use and products obtained thereby

Also Published As

Publication number Publication date
JP3326172B2 (ja) 2002-09-17
DE68928899T4 (de) 1999-11-25
NZ229538A (en) 1992-01-29
JP2002191383A (ja) 2002-07-09
KR900701819A (ko) 1990-12-04
KR0137961B1 (ko) 1998-04-30
DE68928899D1 (de) 1999-02-18
ATE175417T1 (de) 1999-01-15
DK191A (da) 1991-01-02
AU3968489A (en) 1990-02-05
CA1339414C (en) 1997-09-02
AU640110B2 (en) 1993-08-19
JPH03505670A (ja) 1991-12-12
EP0423224A1 (en) 1991-04-24
JP3418388B2 (ja) 2003-06-23
DE68928899T2 (de) 1999-08-12
ZA894721B (en) 1990-03-28
NO905638L (no) 1990-12-28
WO1990000558A1 (en) 1990-01-25
NO905638D0 (no) 1990-12-28
US5218101A (en) 1993-06-08
IL90832A (en) 1995-06-29
IL90832A0 (en) 1990-01-18
EP0423224B1 (en) 1999-01-07
NO309200B1 (no) 2000-12-27
EP0423224A4 (en) 1991-11-06

Similar Documents

Publication Publication Date Title
DK191D0 (da) Ledersekvens, der frembringer en post-translational modifikation af polypeptider i bakterier, samt gen derfor
DE68927088D1 (de) Menschlicher Gefässpermeabilitätsfaktor
DK1019073T3 (da) Apoliprotein A-I agonister og deres anvendelse til at behandle dyslipidæmiske lidelser
NL300062I2 (nl) Osteogene middelen.
EP0324647A3 (en) Vector for the expression of fusion proteins and protein immunogens
DK0643767T3 (da) Osteogene peptider
ATE138102T1 (de) Verfahren zur herstellung von cysteinfreien peptiden
DK0532587T3 (da) Fremgangsmåder til trans-destabilisering af specifikke proteiner in vivo
DK156592D0 (da) Human-h1-praeprorelaxin, -prorelaxin og -relaxin samt polypeptid med relaxinaktivitet og fremgangsmaade til sammenfoejning af a- og b-kaederne i human-h1-relaxin
DK3688A (da) Pankreatisk sekretorisk trypsininhibitor og varianter deraf fremstillet af en rekombinant vaert, fremgangsmaade, ekspressionsvektor og rekombinant vaert samt farmaceutisk anvendelse deraf
ES548617A0 (es) Procedimiento para disociar peptidos y proteinas en el enla-ce metionilo
BR9809416A (pt) Processo para clivagem de proteìnas de fusão
DE3873273D1 (de) Verfahren zur selektiven spaltung von fusionsproteinen.
ES2078229T3 (es) Procedimiento para la preparacion de un polipeptido similar a la motilina y su expresion.
DK196689A (da) Ekspression af praes2-proteinet for hepatitis b i methylotrophe gaerarter
DK0467839T3 (da) In-vitro-behandling af fusionsproteiner
ES2056872T3 (es) Proteina pp4-x anticoagulante, su preparacion y empleo.
ATE110775T1 (de) Verfahren zur herstellung von hirudin.
ES2080326T3 (es) Proteinas similares a ancrod, su obtencion y empleo.
ATE416781T1 (de) Antigene modifikation von polypeptiden
NZ230996A (en) Immunogenic recombinant polypeptides and their use in the production of neutralising antibodies against viral haemorrhagic septicaemia virus
ATE91303T1 (de) Verfahren zur herstellung von peptiden durch spezifische spaltung von gentechnisch gewonnenen fusionsproteinen mit collagenasen.
DE59203874D1 (de) Schizosaccharomyces-spezifische Polypeptide.
NO893572D0 (no) Lunge-overflateaktivt protein og beslektet polypeptid.
LV5812A4 (lv) Polipeptida iegusanas panemiens ekspresijas vektors un dns secibas

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment